MarginsXMarginsX
Home › Markets › PURE

Pure Bioscience, Inc. (PURE)

PURE is quoted over the counter, not listed on an exchange. Pure Bioscience, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.0600
-14.3% on the day
1-year return
+20.0%
Market cap
$8.4M
Nano cap. From the Nov 16, 2026 close × 140.2M shares (10-K cover page, Oct 29, 2026)
P/E and P/S
Net loss over the period · 3.6×
On trailing twelve months to July 31, 2026 (10-K)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerPURE, quoted over the counter
SEC CIK0001006028
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codeMiscellaneous Chemical Products
Business addressEl Cajon, CA
Incorporated inDE

Warning signs

Cash runway
3.9 months
$569K cash at July 31, 2026
Share count, 1 year
+25.3%
2025-10-29 to 2026-10-29 · +25.3% over 3 years
Going-concern doubt
Yes
10-K filed October 29, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of this report."
10-K 2026-10-29
Cash and burn$569K cash; operating cash flow -$435K a quarter.Report 2026-07-31
Shares outstanding140,201,055 (2026-10-29); 111,886,473 a year earlier; 111,856,473 three years earlier.Cover page 2026-10-29
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorWeinberg & Company, P.A., Los Angeles, California, United StatesPCAOB Form AP 2026-11-04
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q4 2026
2026-07-31
$659K-$610K-$414K$569K$6.6M$2.3M10-K 2026-10-29
Q3 2026
2026-04-30
$506K-$624K-$468K$983K$15.0M$2.4M10-Q 2026-06-15
Q2 2026
2026-01-31
$443K-$785K-$606K$198K$11.7M$2.4M10-Q 2026-03-17
Q1 2026
2025-10-31
$707K-$464K-$250K$434K$10.8M$2.4M10-Q 2025-12-15
Q4 2025
2025-07-31
$763K-$332K-$456K$334K$11.2M$2.2M10-K 2026-10-29
Q3 2025
2025-04-30
$489K-$580K-$512K$540K$4.9M$1.9M10-Q 2026-06-15
Q2 2025
2025-01-31
$391K-$798K-$544K$202K$4.0M$1.9M10-Q 2026-03-17
Q1 2025
2024-10-31
$555K-$689K-$503K$346K$3.5M$1.8M10-Q 2025-12-15

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentPOS AM2020-10-20
Latest annual report10-K2026-10-29
Latest quarterly / interim10-Q2026-06-15
Latest current report8-K2026-10-29
Latest proxyDEF 14A2025-12-30

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier